Barrons.com69d agobearish
Medtronic Stock Is Defying a Market Selloff After Earnings. Here’s Why.The medical device maker posts fiscal fourth-quarter earnings and revenue that narrowly beat analysts’ estimates.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
354last 24h
2375last 7d
429● bullish (7d)
221● bearish (7d)
202publishers
Motley Fool76d agobearish
Stock Market Today, May 27: Boston Scientific Plunges After Reiterating Underwhelming Full Year Growth GuidanceInvestors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026.
The Wall Street Journal83d agoneutral
Biotech Investors Are Tuning Out the MAHA ChaosThe Food and Drug Administration is rudderless. Its commissioner, Marty Makary, is gone. The rise of the Make America Healthy Again movement, with its vaccine skepticism and adversarial stance toward drugmakers, has hung over biotech since Robert F. Kennedy Jr. took over at the Department of Health and Human Services.
Bloomberg88d agoneutral
Trump Traded Nvidia, Boeing, Intel in Flurry of Transactions(Bloomberg) -- President Donald Trump’s latest financial disclosures show that he made a slew of stock and bond purchases with major American companies in the first quarter of the year totaling in the tens of millions of dollars and possibly more. Most Read from BloombergHormuz Oil Flows Creep Higher as More Supertankers ExitIran’s Kharg Island Oil Jetties Empty Again Yesterday, Satellite ShowsWhat Is The Thucydides Trap and Why Did Xi Raise It With Trump?Xi Tells US CEOs on Trump Visit That Chi
MarketBeat94d agoneutral
Tandem Diabetes Care Q1 Earnings Call HighlightsTandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward pharmacy-channel reimbursement, expands direct international operations and prepares several product
Reuters103d agoneutral
Dexcom reaffirms full-year forecast after topping quarterly estimatesApril 30 (Reuters) - Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for quarterly results, helped by strong demand for its